Title: Extracorporeal Membrane Oxygenation Market
1 Extracorporeal Membrane Oxygenation Market
Research Report Analysis and Forecasts to 2032
2023 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
2Market Scenario of Extracorporeal Membrane
Oxygenation Market
- Extracorporeal Membrane Oxygenation Market report
gives attention to market segmentation, market
size, and forecast of 2023-2032 to help
stakeholders in making a good decision for the
future investments. Urinary Catheters industry
report segmented into types, application, and
regions with providing production, revenue,
import/export. - The global extracorporeal membrane oxygenation
(ECMO) market is speculated to grow significantly
through 2032 owing to increasing government
initiatives as well as programs in Europe. - The prevalence of respiratory and cardiovascular
illnesses has increased dramatically throughout
the European region in recent years, and this
trend is expected to continue over the forecast
time. - An increase in CVD cases has led to introduction
of government measures and implementation of
different programs in the area to raise public
awareness. Government funding for infrastructure
development in emerging nations would help make
expensive machines more accessible, which will
boost industry revenue growth.
2023 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
3Continue-
- For instance, in January 2021, Braile Biomedica,
in collaboration with the Eldorado Institute and
Embrapii, introduced the SOLIS System, a
nationwide product against COVID-19.
Extracorporeal membrane oxygenation (ECMO), a
type of extracorporeal breathing, makes up the
system. The corporation has benefited from such
product introductions in securing its market
position. - The ECMO market has been divided in terms of
approach, type, patient population, and region. - Based on approach, the veno-venous (VV) segment
held more than 180 million in 2022. The
veno-venous ECMO device increases blood flow and
oxygen levels while reducing cardiac effort and
supporting hemodynamics. There will likely be a
rise in demand for veno-venous ECMO through the
forecast years due to the growing burden of
cardiopulmonary diseases.
2023 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
4360 Industry Analysis
- With respect to type, the respiratory segment is
poised to grow at more than 3 CAGR from 2023 to
2032. A significant factor in the segment's
growth is the risk of respiratory failure among
individuals with different respiratory illnesses.
Besides, the expanding geriatric population that
is vulnerable to respiratory ailments, would
further complement the growing market landscape. - In terms of the patient population, the adult
segment is projected to foresee positive market
expansion through the forecast years. The need
for ECMO treatments will be driven by the growing
elderly population base and the rise in the
number of people with infectious and chronic
diseases. Moreover, advancements in ECMO
technology for treating adults is likely to
contribute to the industry expansion. - From the regional front, the Latin America
extracorporeal membrane oxygenation (ECMO) market
is estimated to grow at more than 4 CAGR from
2023 to 2032. The expansion is fueled by the
burgeoning use of cutting-edge ECMO technology in
healthcare settings in LATAM nations along with
the region's rising respiratory and cardiac
disease rates. Additionally, the regional
expansion will also benefit from the increased
ECMO device demand in the COVID-19-affected
nations.
2023 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
5- Key Players are
- Abbott Laboratories
- Fresenius Medical Care AG Co. KGaA
- Braile Biomedica
- Edwards Lifesciences Corporation
- Abiomed
- Eurosets
2023 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
6Stay In Touch You can visit us at
www.gminsights.com
Thank You!
2023 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com